Skip to main content
logo
HomeStocksSAKAR

S

Sakar Healthcare

₹ 1,075.70

47.05 (4.57%)profit
as on 11 Nov 2026 at 03:29 PM

NSE

views820
portfolio377
analyst100% Buy
Overview
Pros & Cons
News
History
Fundamentals
Investment Returns
Technicals
Financials
Balance Sheet
Cash Flow
Corporate Actions
Peers

Sakar Healthcare Share Price Today

Sakar Healthcare (SAKAR) share price is trading at ₹1,075.70 on the NSE as of November 11, 2026 at 03:29 PM, up by 4.57% from its previous close of ₹1,028.65. In todays trading session SAKAR reached a high of 1,080.00 and low of 1,042.00. The average traded price for today is 1,062.31. The 50 DMA stands at 1,028.81 and 200 DMA is at 765.63. Looking at intraday trend, the stock is in Uptrend.

Stock Overview

  • Symbol : SAKAR
  • Open : ₹1,059.00
  • Previous Close : ₹1,028.65
  • Day's Range : ₹1,042.00 – ₹1,080.00
  • 52-Week Range : ₹352.50 – ₹1,229.85
Trading Charts Logo

Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.

Go to Charts

SAKAR Stock Performance

Markets Today

High

1,080.00

Low

1,042.00

Open at

1,059.00

Prev Close

1,028.65

Volumes

1,17,968

Avg Price

1,062.31

Lower Circuit

860.60

Upper Circuit

1,290.80

Last Traded Details

Quantity

25

Time

15:29:52

Price Movement

1,042.001,080.00
3.23%Loss
down side
up side
0.40%Profit

Historical Performance

3 M High

1,229.85

3 M Low

831.55

1 Yr High

1,229.85

1 Yr Low

352.50

3 Yr High

1,229.85

3 Yr Low

210.10

5 Yr High

1,229.85

5 Yr Low

103.35

1-Year Performance

352.501,229.85
205.16%Loss
down side
up side
12.53%Profit

SAKAR Pros and Cons

byfuzz AI

Revenue grew from ₹5,756 Cr in Q2 FY26 to ₹8,742 Cr in Q2 FY27 — sales momentum is strong

EBITDA rose from ₹1,135 Cr in Q2 FY26 to ₹2,435 Cr in Q2 FY27 — operating profits are scaling

Basic EPS increased from ₹2.03 in Q2 FY26 to ₹5.08 in Q2 FY27 — earnings per share have more than doubled

Marketing authorisations received rose from 11 in Q3 FY26 to 22 in Q2 FY27 — market access is improving

Current borrowings fell from ₹2,661 Cr in Q2 FY26 to ₹1,301 Cr in Q2 FY27 — near-term debt burden has eased

Inventories rose from ₹4,453 Cr in Q2 FY26 to ₹9,721 Cr in Q2 FY27 — working capital is building up

Gross margin eased from 60% in Q4 FY26 to 48% in Q2 FY27 — profitability is cooling from the peak

Trade payables rose from ₹3,603 Cr in Q2 FY26 to ₹6,225 Cr in Q2 FY27 — supplier financing is increasing

Employee expenses rose from ₹834 Cr in Q2 FY26 to ₹976 Cr in Q2 FY27 — cost base is higher

fuzz Insights
Positive

Stronger operating cash profit is reducing near-term debt.

Neutral

Factory profit looks strong. Final profit is much smaller.

Neutral

Stock build is being funded by supplier credit.

Neutral

Filing pipeline is much larger than confirmed ingredients.

Neutral

Market approvals are far ahead of approved ingredients.

Negative

Sales jumped, but the profit kept per sale slipped.

SAKAR Analyst Rating

Buy

Analysts have suggested that investors can Buy this Stock

- By Refinitiv from 1 analysts

Buy

100%

Hold

0%

Sell

0%

Get forecast for Price, ROA & ROE based on analyst ratings.

Get Forecast

SAKAR Share Price History

SAKAR Fundamentals

Company Valuation

Market Cap (₹ Cr.)

2,393

PE Ratio

53.40

PB Ratio

6.62

Dividend Yield

-

ROE

9.40%

ROCE

12.82%

Book Value (₹)

155.50

Face Value (₹)

10.00

Analyse SAKAR with 12+ custom fundamentals and financial ratios.

Analyse Now

Share Holding Pattern

Held BySep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters
52.86%52.86%52.86%52.52%51.70%
Domestic Institutional Investors (DII)
0.00%11.36%11.32%11.37%11.92%
Foreign Institutional Investors (FII)
0.00%0.00%12.94%12.14%12.34%
Public Investors
16.01%16.59%18.11%19.96%20.42%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government

Sakar Healthcare Return Calculator

Current value of ₹1,00,000 invested 5 years ago, as on today

₹ 0

Gain

₹ 1,00,000 (613.33%)

Note: Past profits do not guarantee future returns.

SAKAR Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.

SAKAR Technicals

Moving Averages

PeriodSimpleSignal
5-SMA1,000.77Bullish
10-SMA976.32Bullish
20-SMA962.87Bullish
50-SMA1,028.81Bearish
100-SMA947.25Bullish
200-SMA765.63Bullish

Technical Indicators

IndicatorValueAction
RSI(14)54.76Neutral
ATR(14)64.60Less Volatile
STOCH(9,6)70.13Neutral
STOCH RSI(14)88.46Overbought
MACD(12,26)11.36Bullish
ADX(14)16.85Weak Trend

Summary of Technical Indicators for SAKAR

Margin on SAKAR

Order TypeMargin to PayLeverageQuantityTrade ValueMargin AmountActions

*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).

SAKAR Financials Summary

View By:
Revenue
EBITDA
Net Profit
EPS
Revenue

In Crores

Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
5971717588

SAKAR Financials

View by

Income Statement

In Cr

Yearly StatementMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
130138157179254
Expenses99100115128183
3238425171
Operating Profit2933385069
Operating Profit Margin %23%25%25%28%27%
Other Income25312
Interest36898
Depreciation1015182124
1917162240
Tax %20%24%27%19%23%
Net Profit1513121831
EPS1076814

Balance Sheet

In Cr

Yearly Balance SheetMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
268336389415481
Fixed Assets205267314309327
Current Assets50567289141
Capital Work in Progress170174
Investments73000
Other Assets55607490151
268336389415481
Current Liabilities47555963110
Non Current Liabilities94109676747
128173262286325
Reserve & Surplus110154236261302
Share Capital1719222222
Minority Interest00000

Cash Flow

In Cr

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Activities3633253449
Investing Activities-90-74-52-31-28
Financing Activities554127-4-21
Net Cash Flow-000-0-0

Corporate Actions

DateCorporate ActionInformation
23rd Oct 2026, Friday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 26-27 Results
info
24th Jul 2026, Friday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q1 FY 26-27 Results
info
12th May 2026, Tuesday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q4 FY 26-27 Results
info
5th Feb 2026, Thursday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q3 FY 25-26 Results
info
7th Nov 2025, Friday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 25-26 Results
info

The above dates are ex-dates.

Check SAKAR latest Company Filings, Investor Presentation & Conference Call details.

Read Now

SAKAR Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2025-26254
41.99% profit
31
74.18% profit
FY 2024-25179
14.29% profit
18
49.96% profit
FY 2023-24157
13.4% profit
12
-8.53% Loss

SAKAR Similar Stocks

Name
LTP
Change %
Volume
Market Cap (Cr.)arrow
PE Ratio
Industry PE
52W High
52W Low
1M Returns
3M Returns
1 Yr Returns
3 Yr Returns
5 Yr Returns
PB Ratio
Dividend Yield
ROE
ROCE
EPS
50 DMA
200 DMA
RSI
Sun Pharmaceutical

S

Sun Pharmaceutical

1,902.30

-0.12%22,62,492₹ 4,56,42541.60-95.962,046.901,583.708.09%-2.20%12.47%61.73%137.39%5.120.84%13.79%17.94%47.801,823.871,813.9670.23
Divis Laboratories

D

Divis Laboratories

11,367.00

-1.72%16,02,464₹ 3,01,75891.3018.9511,824.005,647.5021.70%37.37%70.77%224.91%129.58%17.070.26%15.32%18.96%96.759,539.047,479.7178.97
Torrent Pharmaceuticals

T

Torrent Pharmaceuticals

4,761.00

-0.40%3,47,916₹ 1,81,09386.5032.585,250.003,602.002.24%-3.31%32.99%132.11%234.42%9.890.79%12.16%9.06%63.924,770.754,539.7156.01
Laurus Labs

L

Laurus Labs

2,429.00

-1.02%41,34,062₹ 1,31,24299.30-95.962,480.00917.9519.27%31.70%147.31%557.02%395.11%21.840.04%16.38%19.67%16.472,063.521,500.9071.99
Zydus Life Science

Z

Zydus Life Science

1,199.50

-1.35%17,97,742₹ 1,19,65128.10-95.961,266.60835.507.34%7.66%27.05%95.85%140.67%4.350.08%16.99%19.24%50.091,159.211,045.6055.42

FAQs on SAKAR

Sakar Healthcare share price as of today is ₹ 1,075.70 as on 11 Nov 2026 at 03:29 PM.
The 52W high of Sakar Healthcare is ₹ 1,229.85 and 52W low is ₹ 352.50 as of 11 Nov 2026 at 15:29.
The past returns of Sakar Healthcare share are -
  • Past 1 year: 186.62%
  • Past 3 years: 184.39%
  • Past 5 years: 613.33%
The PE and PB ratio of Sakar Healthcare stands at 53.40 and 6.62 respectively as on 11 Nov 2026 at 15:29.
The EPS of Sakar Healthcare is 5.08 for the quarter ended Sep 2026 and 13.70 for the financial year 2025-26.
The shareholding pattern of Sakar Healthcare is as follows:
  • DIIs - 11.92%
  • FII - 12.34%
  • Promoters - 51.70%
  • Public Investors 20.42%
  • Goverenment - 0.00%
Yes, you can buy shares of Sakar Healthcare online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Sakar Healthcare stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Sakar Healthcare share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Sakar Healthcare.
You can easily buy the shares of Sakar Healthcare even after the markets are closed using the After Market Order feature on Dhan Trading App.


Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES/SMART ODR Portal: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com›store›apps›sebiscores iOS: https://apps.apple.com›app›sebiscores.


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

SEBI presents Samajh Se Investing Simple:

  • Understand Before You Invest
  • Choose Regulated Investment Products
  • Start Early, Stay Invested
  • Beware of Investment Frauds

Reporting of Short Sell Transactions by Clients:

Clients must report any short sale transaction, by emailing help@dhan.co with the subject “Reporting of Short Sell” on the same day.


Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details | MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors | Master Circular for Online Dispute Resolution